Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Nipro Corporation, along with its various subsidiaries, operates as a diversified global enterprise primarily focusing on three key sectors: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device division is responsible for the development, production, and distribution of essential healthcare equipment. This includes products for injection-infusion therapies, dialysis treatments, and solutions for diabetes and cell culture applications, alongside artificial organ-related merchandise. Within the Pharmaceutical segment, Nipro offers a range of innovative combination products, such as dual chamber bags, pre-filled syringes, and convenient half-type kits. Furthermore, it provides comprehensive contract manufacturing services for orally administered, injectable, and topical drugs, complemented by robust logistic and distribution capabilities. The Pharma Packaging division specializes in delivering a complete portfolio of pharmaceutical containers. This encompasses a wide variety of glass products, including vials, ampoules, syringes, and cartridges, alongside glass tubes and glass bulbs designed for vacuum flasks, as well as critical components like rubber plugs. Beyond these core areas, Nipro also manufactures thermostable enzymes vital for clinical chemistry applications through its 'Other business' unit. Additionally, the corporation provides business management services. Established in Osaka, Japan, in 1947, Nipro Corporation maintains a significant international presence, serving markets across Japan, the Americas, Europe, and other parts of Asia.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/
Target Price
The average target price of 8086.T is 1787 and suggests 13.8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat